Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions [PDF]
, 2015 Small vessel disease encompasses lacunar stroke, white matter hyperintensities, lacunes and microbleeds. It causes a quarter of all ischemic strokes, is the commonest cause of vascular dementia, and the cause is incompletely understood.
Bath PMW +4 more
core +2 more sources
Neurology and Therapy, 2019 Introduction Recent studies show that spasticity occurs in 20–30% of all stroke victims, especially in younger patients. Botulinum toxin is a very effective treatment; however, it is not reimbursed in the Ukraine, thus leaving patients untreated and ...
Nataliia Chemer, Volodymyr Bilanovskyi
doaj +1 more source
Transgenic mouse models of childhood-onset psychiatric disorders [PDF]
, 2011 Available in PMC 2012 April 1.Childhood-onset psychiatric disorders, such as attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), mood disorders, obsessive compulsive spectrum disorders (OCSD), and schizophrenia (SZ), affect ...
Feng, Guoping, Robertson, Holly Rochelle
core +1 more source
Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke
Neuropsychiatric Disease and Treatment, 2014 Mohammad Reza Amiri-Nikpour,1 Surena Nazarbaghi,1 Babak Ahmadi-Salmasi,1 Tayebeh Mokari,2 Urya Tahamtan,2 Yousef Rezaei3 1Department of Neurology, Imam Khomeini Hospital, 2School of Medicine, 3Seyyed-al-Shohada Heart Center, Urmia University of Medical ...
Amiri-Nikpour MR +5 more
doaj
Frontiers in PharmacologyBackgroundThe optimal timing of anticoagulation resumption after acute ischemic stroke remains uncertain, particularly in patients at elevated risk of hemorrhagic transformation (HT).
Mikhail N. Kalinin +3 more
doaj +1 more source
Analysis of quantification methods used for cell viability, cell morphology, and synaptic formation in modeling HIV associated dementia in primary neuronal cultures. [PDF]
, 2009 Change is inevitable, changes in neuronal function occur in physiologic and pathologic processes. The ability to reliably analyze and quantify those changes in neuronal morphology and function has been an important part of technical developments in ...
Saunders, John James
core
Neuroprotective and anticonvulsant effects of Cerebrolysin in the experiment
Фармакокинетика и Фармакодинамика, 2017 Purpose of the study. Assess anticonvulsant and neuroprotective effects of Cerebrolysin in rats. Material and methods. The study was carried out on 30 white male rats, who received a course of Cerebrolysin.
T. E. Bogacheva +4 more
doaj
Added value of acute multimodal CT-based imaging (MCTI) : a comprehensive analysis [PDF]
, 2015 Introduction: MCTI is used to assess acute ischemic stroke (AIS) patients.We postulated that use of MCTI improves patient outcome regardingindependence and mortality.Methods: From the ASTRAL registry, all patients with an AIS and a non-contrast-CT (NCCT),
Bill, O., Faouzi, M.F., Michel, P.M.
core
Use of Neuroprotective agents for Traumatic Brain Injury [PDF]
, 2019 Traumatic brain injury (TBI) is the leading cause of mortality and morbidity especially in young ages, while over 30 years of neuroprotective agents use for TBI management provided neither any recommended agent for favorable outcome nor less adverse ...
Meshkini, Ali +2 more
core +2 more sources
Drug-based neuroprotection in acute phase of traumatic brain injury of moderate severity
Медицинский совет, 2015 Traumatic brain injury (TBI) is one of the most common types of brain injuries and is one of the major causes of death and disability among the population.
A. E. Talypov +4 more
doaj +1 more source